RxSearch

NDC properties for "adalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)" (RxCUI 2680756)

About this data

The tables show NDC propoerties for adalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) with the RxCUI 2680756

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for adalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count) (RxCUI 2680756)

BLABLA761058
MMSL_CODEBD40586
RxCUI2680756
SPL_SET_ID62f39a7c-00df-4519-a8d4-39bbd0a649ed
VUID4043139
Prescribable Synonymadalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)
RXNAV_STR{4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector) } Pack
RxNorm Name{4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector) } Pack
RxNorm Synonymadalimumab-adbm Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)
Related queriesInteractions (for RxCUI 2680756)



NDC Properties

NDC Item 00597057540

NDC 90597-0575
NDC 100597-0575-40
NDC Item00597057540
Packaging4 KIT in 1 CARTON (0597-0575-40) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0570-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET
BLABLA761058
FDA SPL set id784593
LabelerBoehringer Ingelheim Pharmaceuticals, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2024-04-30
Marketing statusACTIVE
Related queriesProperties for NDC 9 0597-0575